Tatiana Beresnev

Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal Chemotherapy

Andrew L. Feldman, Steven K. Libutti, James F. Pingpank et al. · Journal of Clinical Oncology · 2003 · 352 citations

Medicine, Oncology, Surgery +12

Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial

Udo Rudloff, Russell C. Langan, John E. Mullinax et al. · Journal of Surgical Oncology · 2014 · 230 citations · Full text

Medicine, Oncology, Surgery +17

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

Marybeth S. Hughes, Jonathan S. Zager, Mark B. Faries et al. · Annals of Surgical Oncology · 2015 · 153 citations · Full text

Medicine, Oncology, Surgery +15

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 128 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +14

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

Cameron R. Wolfe, Kay M Tomashek, Thomas F. Patterson et al. · The Lancet Respiratory Medicine · 2022 · 128 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +3